Showing results (71-80 of 541) with videos related to
Sort By:
Pageof 55
AIDS Reviews|December 19, 2008
Boosted protease inhibitor-based or nonnucleoside reverse transcriptase-based HAART: is there a best choice for antiretroviral-naive HIV-1 infected patients?Lise Cuzin, Clotilde Allavena, Philippe Morlat, et al.AIDS Reviews|December 19, 2008
Role of genetic diversity amongst HIV-1 non-B subtypes in drug resistance: a systematic review of virologic and biochemical evidenceJorge L Martínez-Cajas, Nitika Pant-Pai, Marina B Klein, et al.AIDS Reviews|November 7, 2007
Management of HCV-related end-stage liver disease in HIV-coinfected patientsNicolás Merchante, Manuel Jiménez-Saenz, Juan A PinedaAIDS Reviews|November 7, 2007
Intracellular destinies: degradation, targeting, assembly, and endocytosis of HIV GagKevin C Klein, Jonathan C Reed, Jaisri R LingappaAIDS Reviews|November 7, 2007
Maturation inhibitors: a new therapeutic class targets the virus structureKarl Salzwedel, David E Martin, Michael SakalianAIDS Reviews|January 16, 2007
Atherosclerosis in HIV patients: a new face for an old disease?Paolo Maggi, Renato Maserati, Gianfranco AntonelliAIDS Reviews|December 11, 2013
Time to HIV-1 RNA suppression below 5 copies/ml during first-line protease inhibitor-based antiretroviral treatment - any impact of residual viremia on treatment success?Diego Ripamonti, Andrew Hill, Erkki Lauthouwers, et al.AIDS Reviews|June 17, 2009
Socio-economic impact of antiretroviral treatment in HIV patients. An economic review of cost savings after introduction of HAARTTeresa Gonzalo, Manuel García Goñi, María Angeles Muñoz-FernándezPageof 55